Overview

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

Status:
Completed

Trial end date:
2010-04-12

Target enrollment:

Participant gender:

Summary

A study in type 2 diabetic subjects on stable metformin therapy to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of co-administering single and multiple oral doses of GSK1292263

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Metformin
Sitagliptin Phosphate